BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schemionek M, Herrmann O, Reher MM, Chatain N, Schubert C, Costa IG, Hänzelmann S, Gusmao EG, Kintsler S, Braunschweig T, Hamilton A, Helgason GV, Copland M, Schwab A, Müller-tidow C, Li S, Holyoake TL, Brümmendorf TH, Koschmieder S. Mtss1 is a critical epigenetically regulated tumor suppressor in CML. Leukemia 2016;30:823-32. [DOI: 10.1038/leu.2015.329] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
Number Citing Articles
1 Zhang L, Liu D, Tang B, Xu A, Huang H, Su Y, Xu J, Deng J, Tang L, Sun C, Hu Y. MicroRNA-324-5p suppresses the migration and invasion of MM cells by inhibiting the SCFβ-TrCP E3 ligase. Oncol Lett 2018;16:5331-8. [PMID: 30250603 DOI: 10.3892/ol.2018.9245] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
2 Chen JX, Wang YP, Zhang X, Li GX, Zheng K, Duan CZ. lncRNA Mtss1 promotes inflammatory responses and secondary brain injury after intracerebral hemorrhage by targeting miR-709 in mice. Brain Res Bull 2020;162:20-9. [PMID: 32442560 DOI: 10.1016/j.brainresbull.2020.04.017] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
3 Krenn PW, Koschmieder S, Fässler R. Kindlin-3 loss curbs chronic myeloid leukemia in mice by mobilizing leukemic stem cells from protective bone marrow niches. Proc Natl Acad Sci U S A 2020;117:24326-35. [PMID: 32929022 DOI: 10.1073/pnas.2009078117] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
4 Agarwal E, Robb CM, Smith LM, Brattain MG, Wang J, Black JD, Chowdhury S. Role of Akt2 in regulation of metastasis suppressor 1 expression and colorectal cancer metastasis. Oncogene 2017;36:3104-18. [PMID: 28068324 DOI: 10.1038/onc.2016.460] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 5.2] [Reference Citation Analysis]
5 Niu LT, Wang YQ, Wong CCL, Gao SX, Mo XD, Huang XJ. Targeting IFN-γ-inducible lysosomal thiol reductase overcomes chemoresistance in AML through regulating the ROS-mediated mitochondrial damage. Transl Oncol 2021;14:101159. [PMID: 34252711 DOI: 10.1016/j.tranon.2021.101159] [Reference Citation Analysis]
6 Luxen D, Gielen GH, Waha A, Isselstein L, Müller T, Koch P, Hammes J, Becker A, Simon M, Wurst P, Endl E, Pietsch T, Gessi M, Waha A. MTSS1 is epigenetically regulated in glioma cells and inhibits glioma cell motility. Transl Oncol 2017;10:70-9. [PMID: 27988423 DOI: 10.1016/j.tranon.2016.11.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
7 Alqahtani K, Taylor CC, Wood HM, Gusnanto A. Sparse modelling of cancer patients' survival based on genomic copy number alterations. J Biomed Inform 2022;:104025. [PMID: 35181494 DOI: 10.1016/j.jbi.2022.104025] [Reference Citation Analysis]
8 Nadeem Abbas M, Kausar S, Wang F, Zhao Y, Cui H. Advances in Targeting the Epidermal Growth Factor Receptor Pathway by Synthetic Products and Its Regulation by Epigenetic Modulators As a Therapy for Glioblastoma. Cells 2019;8:E350. [PMID: 31013819 DOI: 10.3390/cells8040350] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
9 Fu R, Qin P, Zou X, Hu Z, Hong N, Wang Y, Jin W. A Comprehensive Characterization of Monoallelic Expression During Hematopoiesis and Leukemogenesis via Single-Cell RNA-Sequencing. Front Cell Dev Biol 2021;9:702897. [PMID: 34722498 DOI: 10.3389/fcell.2021.702897] [Reference Citation Analysis]
10 Grandits AM, Nguyen CH, Schlerka A, Hackl H, Sill H, Etzler J, Heyes E, Stoiber D, Grebien F, Heller G, Wieser R. Downregulation of MTSS1 in acute myeloid leukemia is associated with a poor prognosis, chemotherapy resistance, and disease aggressiveness. Leukemia 2021. [PMID: 33782537 DOI: 10.1038/s41375-021-01224-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Vadakekolathu J, Al-Juboori SIK, Johnson C, Schneider A, Buczek ME, Di Biase A, Pockley AG, Ball GR, Powe DG, Regad T. MTSS1 and SCAMP1 cooperate to prevent invasion in breast cancer. Cell Death Dis 2018;9:344. [PMID: 29497041 DOI: 10.1038/s41419-018-0364-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
12 Parting O, Langer S, Kuepper MK, Wessling C, Li S, Braunschweig T, Chatain N, Maié T, Costa IG, Crysandt M, Huber M, Brümmendorf TH, Koschmieder S, Schemionek M. Therapeutic inhibition of FcγRIIb signaling targets leukemic stem cells in chronic myeloid leukemia. Leukemia 2020;34:2635-47. [PMID: 32684632 DOI: 10.1038/s41375-020-0977-8] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Fahrenkamp D, Herrmann O, Koschmieder S, Brümmendorf TH, Schemionek M. Mtss1(CSC156) mutant mice fail to display efficient Mtss1 protein depletion. Leukemia 2017;31:1017-9. [PMID: 28167834 DOI: 10.1038/leu.2017.19] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
14 Abdulmawjood B, Costa B, Roma-Rodrigues C, Baptista PV, Fernandes AR. Genetic Biomarkers in Chronic Myeloid Leukemia: What Have We Learned So Far? Int J Mol Sci 2021;22:12516. [PMID: 34830398 DOI: 10.3390/ijms222212516] [Reference Citation Analysis]
15 Baumeister J, Maié T, Chatain N, Gan L, Weinbergerova B, de Toledo MAS, Eschweiler J, Maurer A, Mayer J, Kubesova B, Racil Z, Schuppert A, Costa I, Koschmieder S, Brümmendorf TH, Gezer D. Early and late stage MPN patients show distinct gene expression profiles in CD34+ cells. Ann Hematol 2021. [PMID: 34390367 DOI: 10.1007/s00277-021-04615-8] [Reference Citation Analysis]
16 Koschmieder S, Vetrie D. Epigenetic dysregulation in chronic myeloid leukaemia: A myriad of mechanisms and therapeutic options. Semin Cancer Biol 2018;51:180-97. [PMID: 28778403 DOI: 10.1016/j.semcancer.2017.07.006] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 5.2] [Reference Citation Analysis]
17 Herrmann O, Kuepper MK, Bütow M, Costa IG, Appelmann I, Beier F, Luedde T, Braunschweig T, Koschmieder S, Brümmendorf TH, Schemionek M. Infliximab therapy together with tyrosine kinase inhibition targets leukemic stem cells in chronic myeloid leukemia. BMC Cancer 2019;19:658. [PMID: 31272418 DOI: 10.1186/s12885-019-5871-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
18 Kuepper MK, Bütow M, Herrmann O, Ziemons J, Chatain N, Maurer A, Kirschner M, Maié T, Costa IG, Eschweiler J, Koschmieder S, Brümmendorf TH, Müller-Newen G, Schemionek M. Stem cell persistence in CML is mediated by extrinsically activated JAK1-STAT3 signaling. Leukemia 2019;33:1964-77. [PMID: 30842608 DOI: 10.1038/s41375-019-0427-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
19 Petrov P, Sarapulov AV, Eöry L, Scielzo C, Scarfò L, Smith J, Burt DW, Mattila PK. Computational analysis of the evolutionarily conserved Missing In Metastasis/Metastasis Suppressor 1 gene predicts novel interactions, regulatory regions and transcriptional control. Sci Rep 2019;9:4155. [PMID: 30858428 DOI: 10.1038/s41598-019-40697-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
20 Behzad MM, Shahrabi S, Jaseb K, Bertacchini J, Ketabchi N, Saki N. Aberrant DNA Methylation in Chronic Myeloid Leukemia: Cell Fate Control, Prognosis, and Therapeutic Response. Biochem Genet 2018;56:149-75. [DOI: 10.1007/s10528-018-9841-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
21 Li L, Baxter SS, Gu N, Ji M, Zhan X. Missing-in-metastasis protein downregulates CXCR4 by promoting ubiquitylation and interaction with small Rab GTPases. J Cell Sci 2017;130:1475-85. [PMID: 28264927 DOI: 10.1242/jcs.198937] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
22 Grandits AM, Wieser R. Gene expression changes contribute to stemness and therapy resistance of relapsed acute myeloid leukemia: roles of SOCS2, CALCRL, MTSS1, and KDM6A. Exp Hematol 2021;99:1-11. [PMID: 34029637 DOI: 10.1016/j.exphem.2021.05.004] [Cited by in F6Publishing: 1] [Reference Citation Analysis]